Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Aytu Biopharma (AYTU) Receivables - Other: 2021

Historic Receivables - Other for Aytu Biopharma (AYTU) over the last 1 years, with Jun 2021 value amounting to $21,000.

Aytu Biopharma's Receivables - Other was N/A to $9,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $9,000, marking a year-over-year change of. This contributed to the annual value of $21,000 for FY2021, which is N/A change from last year.
Aytu Biopharma's Receivables - Other amounted to $21,000 in FY2021.
Over the past 5 years, Aytu Biopharma's Receivables - Other peaked at $21,000 during FY2021, and registered a low of $21,000 during FY2021.
Moreover, its 1-year median value for Receivables - Other was $21,000 (2021), whereas its average is $21,000.